Share Dilution from Stock Options
First written in FY2016. 14 of 28 entries say "Materialised", first in FY2019-Q2. Latest entry: FY2026.
Sms moved to the "Worse" side of this theme in 2016, 4 years before the typical company in this theme (2020).
The whole theme swung hardest in 2017: 37 of 68 companies on the "Worse" side.
69 other companies' latest entry also says "Materialised".
- FY2026MaterialisedAnnual report
「Status of disposal and holdings of treasury shares acquired during the fiscal year Other (exercise of share acquisition rights) 600」
The Company disposed of 600 treasury shares upon the exercise of share acquisition rights, meaning that part of the potential dilution from potential shares materialized as an actual disposal of shares. - FY2026-H1WorsenedAnnual report
「Class, details and number of shares underlying the share acquisition rights ※ (Note 1) Common shares 237,000 shares」
Series 21 Share Acquisition Rights were issued on 24 July 2025, covering 237,000 shares, with an exercise period from 1 July 2028 to 30 June 2033. This added to the potential dilution exposure. - FY2025-H1WorsenedAnnual report
「株式会社エス・エム・エス Series 20 Share Acquisition Rights Class, details and number of shares underlying the share acquisition rights Common shares 231,000 shares」
For the Series 20 Share Acquisition Rights issued on 24 July 2024, the document states that they cover 231,000 shares and have an exercise period from 1 July 2027 to 30 June 2032. This added to the potential dilution exposure. - FY2024MaterialisedAnnual report
「The 408,100-share increase in issued shares during the fiscal year was attributable to the exercise of share acquisition rights. The 853,691-share increase in treasury shares during the fiscal year was attributable to the acquisition of treasury shares based on a resolution of the Board of Directors meeting held on 27 October 2023 and the purchase of odd-lot shares. The 41,500-share decrease in treasury shares during the fiscal year was attributable to the exercise of share acquisition rights.」
Although 408,100 shares were issued upon the exercise of share acquisition rights during the full fiscal year, the practice of allocating treasury shares continued from the third quarter onward, resulting in a 41,500-share decrease in treasury shares. - FY2024-Q3MitigatedAnnual report
「From the third quarter, treasury shares held by the Company have been allocated upon the exercise of share acquisition rights, so there has been no change in the number of shares issued in connection with the exercises.」
The Company shifted to allocating its treasury shares upon the exercise of share acquisition rights, and the number of issued shares did not increase in connection with exercises during the third quarter. - FY2024-Q2MaterialisedAnnual report
「1 July 2023–30 September 2023 (Note) 402,000 87,561,600 232 2,551 232 2,526 (Note) The total number of issued shares increased by 402,000 shares, and capital and capital reserves each increased by ¥232 million as a result of the exercise of share acquisition rights.」
During the second quarter, 402,000 shares were issued upon the exercise of share acquisition rights, and capital and capital reserves each increased by ¥232 million. Part of the potential dilution from potential shares thus materialized as actual share issuance. - FY2024-Q1WorsenedAnnual report
「株式会社エス・エム・エス Series 19 Share Acquisition Rights Number of shares underlying the share acquisition rights (shares) (Note 1) 213,000」
Series 19 Share Acquisition Rights were issued, covering 213,000 shares, with an exercise period from 1 July 2026 to 30 June 2031, adding to the potential dilution exposure. In addition, 400,000 shares were issued upon the exercise of share acquisition rights in July 2023. - FY2023MaterialisedAnnual report
「1 April 2022–31 March 2023 5,700」
During the fiscal year, 5,700 shares were issued upon the exercise of share acquisition rights, meaning that part of the potential dilution from potential shares materialized as actual share issuance. - FY2023-Q3MaterialisedAnnual report
「The total number of issued shares increased by 2,900 shares, and capital and capital reserves each increased by ¥2 million as a result of the exercise of share acquisition rights.」
During the third quarter, 2,900 shares were issued upon the exercise of share acquisition rights, meaning that part of the potential dilution from potential shares materialized as actual share issuance. - FY2023-Q2MaterialisedAnnual report
「The total number of issued shares increased by 700 shares, and capital and capital reserves each increased by ¥1 million as a result of the exercise of share acquisition rights.」
During the second quarter, 700 shares were issued upon the exercise of share acquisition rights, meaning that part of the potential dilution from potential shares materialized as actual share issuance. - FY2023-Q1WorsenedAnnual report
「株式会社エス・エム・エス Series 18 Share Acquisition Rights」
Series 18 Share Acquisition Rights were issued on 27 July 2022, covering 192,000 shares, with an exercise period from 1 July 2025 to 30 June 2030. This added to the potential dilution exposure. - FY2022-Q3MaterialisedAnnual report
「1 October 2021–31 December 2021 1,500」
During the third quarter, 1,500 shares were issued upon the exercise of share acquisition rights. A further 17,100 shares were issued in January 2022, meaning that part of the potential dilution from potential shares materialized as actual share issuance. - FY2022-Q2WorsenedAnnual report
「株式会社エス・エム・エス Series 17 Share Acquisition Rights Number of shares underlying the share acquisition rights (shares) ※ (Note 1) 183,000」
Series 17 Share Acquisition Rights were issued covering 183,000 shares, adding to the potential dilution exposure. During the second quarter, 5,500 shares were issued upon the exercise of share acquisition rights, meaning that part of the potential dilution materialized as actual share issuance. - FY2022-Q1MaterialisedAnnual report
「1 April 2021–30 June 2021 14,000」
During the first quarter, 14,000 shares were issued upon the exercise of share acquisition rights. A further 3,600 shares were issued in July 2021, after the quarter-end, meaning that part of the potential dilution from potential shares materialized as actual share issuance. - FY2021WorsenedAnnual report
「株式会社エス・エム・エス Series 16 Share Acquisition Rights Number of shares underlying the share acquisition rights (shares) 200,000」
Series 16 Share Acquisition Rights were issued covering 200,000 shares, adding to the potential dilution exposure. During the fiscal year, 52,000 shares were also issued upon the exercise of share acquisition rights. - FY2021-Q3MaterialisedAnnual report
「The total number of issued shares increased by 15,600 shares, and capital and capital reserves each increased by ¥9 million as a result of the exercise of share acquisition rights.」
During the third quarter, 15,600 shares were issued upon the exercise of share acquisition rights, meaning that part of the potential dilution from potential shares materialized as actual share issuance. - FY2021-Q2MaterialisedAnnual report
「The total number of issued shares increased by 31,400 shares, and capital and capital reserves each increased by ¥20 million as a result of the exercise of share acquisition rights.」
During the second quarter, 31,400 shares were issued upon the exercise of share acquisition rights, meaning that part of the potential dilution from potential shares materialized as actual share issuance. A further 7,400 shares were issued in October 2020. - FY2021-Q1WorsenedAnnual report
「株式会社エス・エム・エス Series 16 Share Acquisition Rights Number of shares underlying the share acquisition rights (shares) (Note 1) 200,000」
Series 16 Share Acquisition Rights were issued covering 200,000 shares, adding to the potential dilution exposure. In addition, 1,000 shares were issued upon exercise during the first quarter and 1,600 shares after the quarter-end. - FY2020-Q3MaterialisedAnnual report
「The total number of issued shares increased by 10,000 shares, and capital and capital reserves each increased by ¥5 million as a result of the exercise of share acquisition rights. Between 1 January 2020 and 31 January 2020, the number of issued shares increased by 6,000 shares as a result of the exercise of share acquisition rights.」
During the third quarter, 10,000 shares were issued upon the exercise of share acquisition rights, followed by a further 6,000 shares after the quarter-end, meaning that part of the potential dilution from potential shares materialized as actual share issuance. - FY2020-Q2WorsenedAnnual report
「株式会社エス・エム・エス Series 15 Share Acquisition Rights Number of shares underlying the share acquisition rights (shares) 254,000」
Series 15 Share Acquisition Rights were issued, covering 254,000 shares, with an exercise period from 1 July 2022 to 30 June 2027. During the second quarter, 38,800 shares were issued upon the exercise of share acquisition rights, adding to and partially realizing the potential dilution exposure. - FY2020-Q1MaterialisedAnnual report
「During the period from 1 July 2019 to 31 July 2019, the exercise of subscription rights to shares increased the number of issued shares by 29,000.」
Although this was after the quarter-end, 29,000 shares were issued upon the exercise of share acquisition rights, meaning that part of the potential dilution from potential shares materialized as an actual share issuance. - FY2019-Q3MaterialisedAnnual report
「1 October 2018–31 December 2018 48,000」
The exercise of subscription rights to shares during the third-quarter accounting period resulted in the issuance of 48,000 shares, with part of the potential dilution from potential shares materializing as an actual share issuance. - FY2019-Q2MaterialisedAnnual report
「The exercise of subscription rights to shares increased the total number of issued shares by 108,800 shares and increased both capital stock and capital surplus by ¥27 million.」
The exercise of subscription rights to shares resulted in the issuance of 108,800 shares, with part of the potential dilution from potential shares materializing as an actual share issuance. - FY2019-Q1WorsenedAnnual report
「At a meeting of the Board of Directors held on 18 July 2018, our company resolved to issue subscription rights to shares to directors and employees of our company and its subsidiaries, and issued them on 7 August 2018. 株式会社エス・エム・エス, Series 14 subscription rights to shares.」
Series 14 subscription rights to shares were issued, adding 180,000 underlying shares. Potential exposure to dilution of equity value has increased. The risk itself is the possibility of future dilution and is distinguished from dilution that has actually occurred. - FY2018WorsenedAnnual report
「As of the end of the current consolidated fiscal year, potential shares under these stock options totaled 658,400 shares, equivalent to 1.49% of the total number of shares, including potential shares.」
The number of potential shares increased from 550,400 shares at the end of the previous fiscal year to 658,400 shares, representing 1.49% of the total number of shares including potential shares. - FY2018-Q1WorsenedAnnual report
「The subscription rights to shares issued during the current first-quarter accounting period are as follows: 株式会社エス・エム・エス, Series 13 subscription rights to shares.」
Series 13 subscription rights to shares were issued, representing 159,000 underlying shares, with an exercise period from 1 July 2020 to 30 June 2025. This added potential exposure to dilution of equity value from subscription rights to shares. - FY2017-Q2WorsenedAnnual report
「The subscription rights to shares issued during the current second-quarter accounting period are as follows.」
Subscription rights to shares, Series 11 and Series 12, were newly issued, representing a total of 224,000 underlying shares. This added potential exposure to dilution of equity value from subscription rights to shares. - FY2016First statedAnnual report
「As of the end of the current consolidated fiscal year, potential shares under these stock options totaled 382,400 shares, equivalent to 0.90% of the total number of shares, including potential shares.」
The potential for dilution of per-share value through the exercise of subscription rights to shares is described.